UNSPSC 51334204: Quetiapine

This classification denotes a serotonin antagonist and antipsychotic agent with the molecular formula C21H25N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BGL0JSY5SI, chemically known as 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol fumarate ( but generally known as quetiapine, which bears US NIH Compound Identifier 5002. European Medicines Agency schedules Quetiapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10192MIG.

UNSPSC 51334204 Quetiapine is a Commodity code that, based on recent state and local solicitations, does not capture the pharmaceutical procurement activity actually being undertaken by state and local agencies. The code names a single antipsychotic medication, yet the recent opportunities posted under this code involve naloxone dispensing systems, direct-to-manufacturer pharmacy prescription programs, and multi-source generic pharmaceuticals and over-the-counter products — none of which are quetiapine or related to its therapeutic class. The mismatch suggests either tagging error in the procurement system or that the code is being used as a catch-all for pharmaceutical commodity solicitations beyond its nominal scope. State and local buyers conducting pharmaceutical procurement are issuing RFPs, RFQs, and IFBs for drugs and delivery systems, but the actual products and clinical areas do not align with quetiapine specifically.

Recent activity includes Seminole County, Florida's IFB 60459723LAS posted June 30, 2026 (due July 26, 2026) for 1,900 units of naloxone and 800 drug deactivation systems annually; the Texas Health and Human Services Commission's RFI HHS0017013 posted April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 posted January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon. The geographic spread covers Florida, Texas, and the upper Midwest, with activity driven by both individual counties and state-level cooperative purchasing vehicles. Without verification that recent opportunities are actually seeking quetiapine specifically, pursue this code only after confirming the issuing agency's actual pharmaceutical need matches the drug's indication and clinical use.